The influence of antidysbiotic medicines on the oral cavity state of patients with chronic pancreatitis

Melnychenko, D. І.; Romanenko, I. G.; Levitsky, A. P.; Selivanskaya, I. О.; Romanova, Y. G.

dc.contributor.author	Melnychenko, D. І.	en
dc.contributor.author	Romanenko, I. G.	en
dc.contributor.author	Levitsky, A. P.	en
dc.contributor.author	Selivanskaya, I. О.	en
dc.contributor.author	Romanova, Y. G.	en
dc.date.accessioned	2020-08-07T06:03:01Z
dc.date.available	2020-08-07T06:03:01Z
dc.date.issued	2014
dc.identifier.citation	The influence of antidysbiotic medicines on the oral cavity state of patients with chronic pancreatitis / D. І. Melnychenko, I. G. Romanenko, A. P. Levitsky, I. О. Selivanskaya, Y. G. Romanova // Journal of Health Sciences. 2014. Vol. 4 (02). P. 097–104.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7714
dc.description.abstract	It was determined that 60 patients with chronic pancreatitis have the increased level of inflammation markers in oral liquid: the activity of elastasa and contens of MDA on the background of the increased ureasa’s activity and decreased lysocim activity, which caused increasing level of oral dysbiosis in 15 times. Treatment complex, which includes antidysbiotic medicines (inulin, kvercetin, chicory), allows to remove the occurrence of oral dysbiosis and inflammation.	en
dc.language.iso	en	en
dc.subject	pancreatitis	en
dc.subject	oral cavity	en
dc.subject	saliva	en
dc.subject	dysbiosis	en
dc.subject	inflammation	en
dc.subject	antidysbiotic medicines	en
dc.title	The influence of antidysbiotic medicines on the oral cavity state of patients with chronic pancreatitis	en
dc.type	Article	en